Production (Stage)
Cabaletta Bio, Inc.
CABA
$1.94
-$0.055-2.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.12M | 12.55M | 6.76M | 6.85M | 6.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.14M | 33.79M | 33.05M | 30.28M | 28.03M |
| Operating Income | -37.14M | -33.79M | -33.05M | -30.28M | -28.03M |
| Income Before Tax | -35.94M | -32.59M | -30.63M | -27.60M | -25.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.94M | -32.59M | -30.63M | -27.60M | -25.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.94M | -32.59M | -30.63M | -27.60M | -25.05M |
| EBIT | -37.14M | -33.79M | -33.05M | -30.28M | -28.03M |
| EBITDA | -36.65M | -33.32M | -32.62M | -29.85M | -27.64M |
| EPS Basic | -0.71 | -0.65 | -0.62 | -0.56 | -0.51 |
| Normalized Basic EPS | -0.44 | -0.41 | -0.39 | -0.35 | -0.32 |
| EPS Diluted | -0.71 | -0.65 | -0.62 | -0.56 | -0.51 |
| Normalized Diluted EPS | -0.44 | -0.41 | -0.39 | -0.35 | -0.32 |
| Average Basic Shares Outstanding | 50.74M | 50.13M | 49.47M | 49.45M | 49.30M |
| Average Diluted Shares Outstanding | 50.74M | 50.13M | 49.47M | 49.45M | 49.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |